0001179110-20-010672.txt : 20201026
0001179110-20-010672.hdr.sgml : 20201026
20201026181934
ACCESSION NUMBER: 0001179110-20-010672
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201022
FILED AS OF DATE: 20201026
DATE AS OF CHANGE: 20201026
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brophy Michael Burkes
CENTRAL INDEX KEY: 0001697362
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37478
FILM NUMBER: 201261652
MAIL ADDRESS:
STREET 1: 201 INDUSTRIAL ROAD, SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Natera, Inc.
CENTRAL INDEX KEY: 0001604821
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 010894487
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 INDUSTRIAL ROAD
STREET 2: SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
BUSINESS PHONE: 650-249-9090
MAIL ADDRESS:
STREET 1: 201 INDUSTRIAL ROAD
STREET 2: SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
4
1
edgar.xml
FORM 4 -
X0306
4
2020-10-22
0
0001604821
Natera, Inc.
NTRA
0001697362
Brophy Michael Burkes
C/O NATERA, INC., 201 INDUSTRIAL ROAD
SUITE 410
SAN CARLOS
CA
94070
0
1
0
0
Chief Financial Officer
Common Stock
2020-10-22
4
M
0
1626
10.41
A
58503
D
Common Stock
2020-10-22
4
S
0
1501
68.6619
D
57002
D
Common Stock
2020-10-22
4
S
0
125
69.3810
D
56877
D
Stock Option (right to buy)
10.41
2020-10-22
4
M
0
1626
0
D
2027-06-08
Common Stock
1626
17258
D
The sales reported in this Form 4 effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 31, 2019. The Reporting Person is subject to a Lock-up Letter Agreement that expires on November 10, 2020. The sale of shares is a permissible exemption under the terms of the Lock-Up Letter Agreement.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.23 to $69.17 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.25 to $69.55 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
These reported shares are subject to restrictions in the Lock-Up Letter Agreement.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 21, 2018 and the remaining shares vest in 36 equal monthly installments thereafter. The exercise of this option is a permissible exemption under the terms of the Lock-Up Letter Agreement.
/s/ Tami Chen, attorney-in-fact
2020-10-26